Key Points
- McKesson EVP Michele Lau sold 2,725 shares at an average price of $990 for roughly $2.70 million, reducing her ownership by 45.63% to 3,247 shares, according to an SEC Form 4 filing.
- McKesson beat quarterly expectations with $9.34 EPS (vs. $9.19 est.) and $106.16 billion in revenue (up 11.4% YoY), and set FY2026 guidance of 38.80–39.20 EPS while analysts’ average current-year EPS forecast is 32.77.
- The company declared a quarterly dividend of $0.82 per share (annualized $3.28, ~0.3% yield) with an ex-dividend/record date of March 2 and payment on April 1; the payout ratio is about 9.4%.
McKesson Corporation (NYSE:MCK - Get Free Report) EVP Michele Lau sold 2,725 shares of the company's stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $990.00, for a total value of $2,697,750.00. Following the completion of the transaction, the executive vice president directly owned 3,247 shares in the company, valued at $3,214,530. This trade represents a 45.63% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
McKesson Trading Down 1.8%
McKesson stock opened at $977.51 on Thursday. McKesson Corporation has a 12 month low of $621.88 and a 12 month high of $999.00. The stock has a fifty day simple moving average of $878.63 and a two-hundred day simple moving average of $813.21. The firm has a market cap of $119.74 billion, a price-to-earnings ratio of 28.11, a PEG ratio of 1.60 and a beta of 0.38.
McKesson (NYSE:MCK - Get Free Report) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. During the same period in the prior year, the company posted $8.03 earnings per share. The company's quarterly revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, equities research analysts forecast that McKesson Corporation will post 32.77 EPS for the current fiscal year.
McKesson Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be issued a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend is Monday, March 2nd. McKesson's payout ratio is presently 9.43%.
Wall Street Analysts Forecast Growth
A number of equities research analysts have commented on the stock. UBS Group lifted their target price on shares of McKesson from $920.00 to $980.00 and gave the stock a "buy" rating in a research report on Thursday, November 6th. Barclays lifted their price objective on McKesson from $960.00 to $1,050.00 and gave the stock an "overweight" rating in a report on Wednesday, February 18th. Weiss Ratings downgraded McKesson from a "buy (a-)" rating to a "buy (b+)" rating in a report on Thursday, February 5th. Mizuho boosted their price target on McKesson from $880.00 to $885.00 and gave the company a "neutral" rating in a research note on Thursday, February 5th. Finally, TD Cowen increased their price objective on shares of McKesson from $1,000.00 to $1,012.00 and gave the stock a "buy" rating in a research note on Thursday, February 5th. Thirteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $943.50.
Read Our Latest Research Report on McKesson
Institutional Trading of McKesson
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Rehmann Capital Advisory Group lifted its position in shares of McKesson by 4.5% during the 4th quarter. Rehmann Capital Advisory Group now owns 2,806 shares of the company's stock valued at $2,303,000 after buying an additional 121 shares in the last quarter. SHP Wealth Management purchased a new stake in McKesson in the 4th quarter worth approximately $1,143,000. Reflection Asset Management bought a new stake in McKesson during the 4th quarter worth approximately $123,000. Wick Capital Partners LLC purchased a new position in McKesson during the fourth quarter valued at approximately $204,000. Finally, Oak Grove Capital LLC bought a new position in shares of McKesson in the fourth quarter worth approximately $205,000. Hedge funds and other institutional investors own 85.07% of the company's stock.
About McKesson
(
Get Free Report)
McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
